Potassium adsorbents lower serum potassium levels but their effects on mortality and rehospitalization rates were unclear. The FDA approved Vafseo (vadadustat) to treat anemia due to chronic kidney disease (CKD) in adults on dialysis. Calyxo, Inc., received FDA clearance for its redesigned CVAC System to aspirate kidney stone fragments. The FDA granted Orphan Drug Designation for felzartamab to treat antibody-mediated rejection in kidney transplant recipients. Researchers sought to determine the palatability of SZC, patiromer, and S/CPS in patients with CKD and hyperkalemia. Experts developed consensus statements for management of hyperkalemia in the Asia–Pacific region. Checkpoint Therapeutics has added Amit Sharma, MD, to its board. The EnAKT LKD trial was designed to target barriers preventing eligible patients from receiving a kidney transplant. Researchers conducted a study to develop an alternative method to reduce bias in estimating mortality due to kidney failure. Kidney transplant recipients are living longer, and their transplanted kidneys are lasting longer, researchers said. The ASN HDU Home Dialysis Scholarship Program will continue in 2024. SGLT2 inhibitors have benefits for anemia risk but their effectiveness among patients with T2D and CKD stage 1-3 was unclear. A Boston area man became the first to receive a genetically modified pig kidney via transplant. A study found that countries in low-resource settings show substantially diminished capacity for kidney care delivery. Humana and Strive Health announced a partnership to provide value-based kidney care to more Medicare Advantage plan members. Kroger has entered into an agreement to sell its specialty pharmacy business to CarelonRx. The home dialysis model is designed to start with peritoneal dialysis and transition to home hemodialysis. The FDA removed two dialysis-related product codes from its device shortage list. The PATIENT Act to provide access to care and affordable oral medicines for CKD is a step closer to becoming law. Researchers studied the association of eGFR and UACR with structural brain abnormalities visible on MRI.